Great Basin Scientific, Inc. Spending and interest coverage
- R&D / revenue · 12 months: Value 418.00%; Formula and calculation Research and development expense / revenue. Period ending 2017-03-31..
- Stock-based compensation / revenue · 12 months: Value (m); Formula and calculation Share-based compensation / revenue. Period ending 2017-03-31..
- Interest coverage · 12 months: Value -0.19×; Formula and calculation Operating income ÷ reported interest expense..
Spending and interest coverage
Overview →Financial period ending 2017-03-31; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| R&D / revenue · 12 months | 418.00% | Research and development expense / revenue. Period ending 2017-03-31. $13.16M ÷ $3.15M × 100 ≈ 418.00% |
| Stock-based compensation / revenue · 12 months | (m) | Share-based compensation / revenue. Period ending 2017-03-31. Calculation unavailable: missing inputs remain (m). |
| Interest coverage · 12 months | -0.19× | Operating income ÷ reported interest expense. $-33.41M ÷ $172.72M ≈ -0.19× |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Research and development spending | 13.16M USD | Research and Development Expense |
| Revenue | 3.15M USD | |
| Stock-based compensation | (m) | |
| Operating income | -33.41M USD | Operating Income (Loss) |
| Interest expense · reported / estimated | 172.72M USD | Interest Expense · Estimated expense assumptions |
Latest interest expense basis: Reported. Estimated values carry *; expand each history row’s basis for its dated balances and rate assumptions.
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Research and development spending (USD) | Revenue (USD) | Stock-based compensation (USD) | Operating income (USD) | Interest expense · reported / estimated (USD) | R&D / revenue | SBC / revenue | Interest coverage | Interest expense basis |
|---|---|---|---|---|---|---|---|---|---|
| 2017-03-31 | $13.16M | $3.15M | (m) | $-33.41M | $172.72M | 418.00% | (m) | -0.19× | Reported |
| 2016-12-31 | $13.41M | $3.05M | (m) | $-34.08M | $167.47M | 439.82% | (m) | -0.20× | Reported |
| 2016-09-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2016-06-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2016-03-31 | $9.28M | $2.41M | (m) | $-25.64M | $17.77M | 384.31% | (m) | -1.44× | Reported |
| 2015-12-31 | $8.49M | $2.14M | (m) | $-22.41M | $11.76M | 396.15% | (m) | -1.91× | Reported |
| 2015-09-30 | $7.63M | $1.98M | (m) | $-19.15M | $1.19M | 386.19% | (m) | -16.15× | Reported |
| 2015-06-30 | $6.18M | $1.84M | (m) | $-15.47M | $1.25M | 335.82% | (m) | -12.41× | Reported |
| 2015-03-31 | $5.30M | $1.72M | (m) | $-13.53M | $1.25M | 308.84% | (m) | -10.83× | Reported |
| 2014-12-31 | $4.61M | $1.61M | (m) | $-12.19M | $1.14M | 287.00% | (m) | -10.73× | Reported |
| 2014-09-30 | $3.93M | $1.46M | (m) | $-11.15M | $989.49K | 269.91% | (m) | -11.27× | Reported |
| 2014-06-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2014-03-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2013-12-31 | $3.35M | $760.65K | (m) | $-9.28M | $284.32K | 439.85% | (m) | -32.64× | Reported |
| 2013-09-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.